ArticleOncotarget2016

Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.

Matthias Riedel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.